Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Hirayama

Showing results (1-10 of 98) with videos related to

Pageof 10
Sort By:
Rinsho Byori. the Japanese Journal of Clinical Pathology|January 30, 2019
[Secondary Dyslipidemia-Diagnosis of Drug-Induced Dyslipidemia-]Satoshi Hirayama
Rinsho Byori. the Japanese Journal of Clinical Pathology|June 18, 2016
[Clinical Application of Methods for the Qualitative Evaluation of Lipid Abnormalities]Satoshi Hirayama
Current Opinion in Lipidology|October 24, 2009
Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular eventsTakashi Miida, Satoshi Hirayama
Rinsho Byori. the Japanese Journal of Clinical Pathology|May 16, 2013
[Genetic predisposition to dyslipidemia]Satoshi Hirayama, Takashi Miida
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 20, 2012
Small dense LDL: An emerging risk factor for cardiovascular diseaseSatoshi Hirayama, Takashi Miida
Rinsho Byori. the Japanese Journal of Clinical Pathology|June 13, 2012
[LDL-cholesterol homogeneous assays versus Friedewald's equation]Takashi Miida, Satoshi Hirayama
Current Opinion in Endocrinology, Diabetes, and Obesity|January 30, 2019
Controversy over the atherogenicity of lipoprotein-XTakashi Miida, Satoshi Hirayama
Rinsho Byori. the Japanese Journal of Clinical Pathology|February 21, 2009
[Lipoproteins and their receptors in the central nervous system]Takashi Miida, Satoshi Hirayama
Rinsho Byori. the Japanese Journal of Clinical Pathology|July 29, 2010
[Recent advances in the research on HDL subfraction]Takashi Miida, Satoshi Hirayama
Photochemistry and Photobiology|February 21, 2004
Oxygen triggering reversible modulation of Vibrio fischeri strain Y1 bioluminescence in vivoHajime Karatani, Susumu Yoshizawa, Satoshi Hirayama
Pageof 10

Showing results (1-10 of 98) with videos related to

Sort By:
Pageof 10
Rinsho Byori. the Japanese Journal of Clinical Pathology|January 30, 2019
[Secondary Dyslipidemia-Diagnosis of Drug-Induced Dyslipidemia-]Satoshi Hirayama
Rinsho Byori. the Japanese Journal of Clinical Pathology|June 18, 2016
[Clinical Application of Methods for the Qualitative Evaluation of Lipid Abnormalities]Satoshi Hirayama
Current Opinion in Lipidology|October 24, 2009
Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular eventsTakashi Miida, Satoshi Hirayama
Rinsho Byori. the Japanese Journal of Clinical Pathology|May 16, 2013
[Genetic predisposition to dyslipidemia]Satoshi Hirayama, Takashi Miida
Clinica Chimica Acta; International Journal of Clinical Chemistry|September 20, 2012
Small dense LDL: An emerging risk factor for cardiovascular diseaseSatoshi Hirayama, Takashi Miida
Rinsho Byori. the Japanese Journal of Clinical Pathology|June 13, 2012
[LDL-cholesterol homogeneous assays versus Friedewald's equation]Takashi Miida, Satoshi Hirayama
Current Opinion in Endocrinology, Diabetes, and Obesity|January 30, 2019
Controversy over the atherogenicity of lipoprotein-XTakashi Miida, Satoshi Hirayama
Rinsho Byori. the Japanese Journal of Clinical Pathology|February 21, 2009
[Lipoproteins and their receptors in the central nervous system]Takashi Miida, Satoshi Hirayama
Rinsho Byori. the Japanese Journal of Clinical Pathology|July 29, 2010
[Recent advances in the research on HDL subfraction]Takashi Miida, Satoshi Hirayama
Photochemistry and Photobiology|February 21, 2004
Oxygen triggering reversible modulation of Vibrio fischeri strain Y1 bioluminescence in vivoHajime Karatani, Susumu Yoshizawa, Satoshi Hirayama
Pageof 10